glp 1 investing research2guidance The Skinny on GLP-1 Investing
Description
Infrequent bowel movements Only one trial was evaluated regarding the risk of infrequent bowel movements in patients receiving GLP-1 RAs
While both are classified as research peptides used in laboratory studies , they differ significantly in receptor targeting and signaling behavior
These are no longer endocrinology or primary care drugs
Data from January 2021 through May 2023 Source: IQVIA LAAD pharmacy and medical claims
Some researchers have also determined the effect of GLP-1 analogs in type 1 diabetes
